JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roca, M.
Right arrow Articles by Díaz, M C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roca, M.
Right arrow Articles by Díaz, M C.
Journal of Nuclear Medicine Vol. 42 No. 3 505-508
© 2001 by Society of Nuclear Medicine


BASIC SCIENCE INVESTIGATIONS

Chemotaxis, Viability, and Labeling Stability of Leukocytes Labeled with 99mTc-Exametazime Stabilized with Methylene Blue

Manuel Roca, Fernando Iglesias, Víctor García, Félix Armero and Ma Carmen Díaz

Radiopharmacy Unit, Nuclear Medicine Department, L’Hospitalet de Llobregat, Ciutat Sanitària Universitària de Bellvitge, Barcelona, Spain

The in vitro viability, chemotaxis, and labeling stability of leukocytes labeled using 99mTc-exametazime stabilized with methylene blue were evaluated and compared with those obtained using nonstabilized 99mTc-exametazime. Methods: Two identical leukocyte populations, from 30 healthy donors, were labeled simultaneously using freshly prepared and 2-h-old stabilized 99mTc-exametazime. The following quality control techniques were performed on each labeled leukocyte sample: eosin Y staining, chemotaxis radioassay, and labeling stability at 2 h after labeling. Results: Eosin Y staining showed a cell viability of at least 98% in all samples, without a significant statistical difference between the populations. Chemotactic indices obtained with leukocytes labeled with freshly prepared, unstabilized 99mTc-exametazime were statistically greater than those obtained using 99mTc-exametazime stabilized with methylene blue (z = 2.41; P < 0.02). Labeling stability at 2 h after labeling was the same for both populations. Conclusion: The use of 99mTc-exametazime stabilized with methylene blue for leukocyte radiolabeling does not affect either cell membrane integrity or labeling stability but can cause a decrease in the cell chemotactic capacity that discourages its clinical use.

Key Words: leukocytes • 99mTc-exametazime • radiopharmaceutical stabilization • methylene blue • chemotaxis




This article has been cited by other articles:


Home page
JNMHome page
J. C. Hung, B. C. Iverson, K. A. Toulouse, and D. W. Mahoney
Effects of Methylene Blue Stabilizer on In Vitro Viability and Chemotaxis of 99mTc-Exametazime-Labeled Leukocytes
J. Nucl. Med., July 1, 2002; 43(7): 928 - 932.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2001 by the Society of Nuclear Medicine.